Fueling firefighters to always Stay Ready with science-backed supplements. | America’s Electrolyte. Sea Salt + Coconut Water.
FERA Diagnostics & Biologicals
FERA is founded by dairy veterinarians and is dedicated to developing innovative solutions to improve welfare, productivity and health for dairy cattle. The diagnostic line centered around AccuMast has improved mastitis culturing around the world by providing rapid, easy to use and accurate on farm testing with its innovative color changing technology. FerAppease is revolutionizing the dairy industry by decreasing the stress response of cows at freshening, dry off, weaning and other stressful times. Look to FERA for innovative animal health solutions to improve animal welfare and your bottom line.
Fedegari Technologies, Inc.
Fedegari is a global leader in providing highly customized integrated solutions for the biotechnological and pharmaceutical industries. Scientific research and technological innovation have the power to improve lives: at Fedegari, this belief drives everything we do. Our Lab Solutions are designed to support those working at the forefront of science, offering high-performance, reliable systems that simplify daily laboratory workflows while ensuring uncompromising process control. Our autoclaves and washing machines are utilized in high-performing pharmaceutical and biopharmaceutical companies, microbiology and R&D laboratories, food processing, cosmetics, agricultural and packaging industries around the world. Our American headquarter is located in the Philadelphia, PA area, and our sales and service network spans the entire USA, Canada, Mexico, and Latin America.
Fapon Biopharma
Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including a platform for discovering biologics based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. We have also built a differentiated pipeline of multiple internationally leading drug candidates. We have established a system that covers different aspects of the drug development from drug discovery, preclinical research, CMC to regulation and early clinical development. We are committed to enabling safer, more efficacious and affordable biologics.
EYED PHARMA
EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts. | Micro-Implants for the Future of Eye Care Founded in 2012, EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts. Our leading clinical-stage product candidate is an intraocular implant allowing a sustained release of API up to 9 years that could ensure 100% patient’s compliance and could considerably reduce treatment side effects, preventing further vision loss and drastically improving the patient’s daily quality of life. To support the development of our innovative R&D pipeline, we built our own Contract and Development Manufacturing Organization (CDMO), UniD Manufacturing, gathering our strong technological expertise and IP in three unique technology platforms, in-house tailor-made equipment, and talented experts in a highly proprietary GMP approved environment. Today, our team gathers 80+ experts and managers with an average of 18 years’ pharmaceutical expertise in our environment-friendly offices and CDMO in the Science Park of Liège, Belgium.
Exelixis, Inc.
Exelixis is innovating next-generation medicines and regimens at the forefront of cancer care. We are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics.
Evotec
Evotec has been a leader in drug discovery and development for over 30 years, offering end-to-end solutions from target identification to clinical trials. Their innovative approach leverages deep disease understanding, cutting-edge technologies, and tailored solutions, supporting collaborations through standalone services, integrated programs, or strategic partnerships to create impactful medicines. | Evotec is a life science company pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure, faster, smarter, and with greater precision. At the heart of our innovation are proprietary platforms including Molecular Patient Databases, PanOmics, and iPSC-based disease modeling, which uniquely support our expertise in small molecules, biologics, cell therapies, and other key modalities. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of more than 4,800 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence. Learn more at www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.
EnquBio
EnquBio is a San Diego-based preclinical CRO built for the complexity of modern drug discovery. We offer an integrated suite of capabilities including biological tissue models, orthotopic in vivo oncology models, iPSC platforms, in vitro pharmacology, and a comprehensive Immunology & Biomarkers platform spanning flow cytometry, MSD multiplex, and protein quantification designed to deliver biologically meaningful, translatable data at every stage of preclinical development. Whether you’re profiling tumor microenvironment biology, evaluating checkpoint inhibitors, advancing ADCs or bispecifics, or characterizing fibrotic or inflammatory disease, EnquBio brings the scientific rigor and platform depth to answer your most critical research questions. We don’t just run assays, we partner with your team to design studies that generate the kind of clean, reproducible, AI-ready data that accelerates decision-making and de-risks your pipeline.
Encompass Pharmaceutical Services, Inc.
Encompass Ophthalmic Development Services, Inc. offers a full range of ophthalmic development and formulation services from pre-formulation through manufacturing scale-up. • Preclinical Support • Consulting • Ophthalmic Drug Formulation • Ophthalmic Drug Delivery • Ex-vivo drug release characterization • Analytical Method Development and Validation • Pre-Clinical Supplies Manufacturing • Manufacturing Process Development, Scale-up, and Validation • GMP Stability Studies • Clinical Supplies and Manufacturing Support
Enamine
Enamine is a global provider of Screening Compounds (small molecules), Building Blocks, Fragments, HTS/AMDE/PK services, and custom synthesis for supporting a wide range of research programs conducted by pharmaceutical and biotech companies, drug discovery centres, academic institutions and other research organizations worldwide. Enamine offers a broad range of targeted libraries covering many of the most important cancer targets. These libraries have been designed using diverse computational approaches and algorithms by Enamine’s CADD team, as well as through collaborations with industry partners and academic groups.